Literature DB >> 27496216

HapLogic: A Predictive Human Leukocyte Antigen-Matching Algorithm to Enhance Rapid Identification of the Optimal Unrelated Hematopoietic Stem Cell Sources for Transplantation.

Jason Dehn1, Michelle Setterholm2, Kelly Buck2, Jane Kempenich2, Beth Beduhn2, Loren Gragert3, Abeer Madbouly2, Stephanie Fingerson2, Martin Maiers2.   

Abstract

The search for a suitable human leukocyte antigen (HLA)-matched unrelated adult stem cell donor (URD) or umbilical cord blood unit (UCB) is a complex process. The National Marrow Donor Program (NMDP) developed a search algorithm known as HapLogic, which is currently provided within the NMDP Traxis application. The HapLogic algorithm has been in use since 2006 and has advanced URD/UCB HLA-matching technology. The algorithm has been shown to have high predictive accuracy, which can streamline URD/UCB selection and drive efficiencies in the search process to the benefit of the stem cell transplantation community. Here, we describe the fundamental components of the NMDP matching algorithm, output, validation, and future directions.
Copyright © 2016 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cord blood unit selection; Donor selection; HLA matching; Predictive algorithm

Mesh:

Substances:

Year:  2016        PMID: 27496216     DOI: 10.1016/j.bbmt.2016.07.022

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  19 in total

1.  Chromosome Y-encoded antigens associate with acute graft-versus-host disease in sex-mismatched stem cell transplant.

Authors:  Wei Wang; Hu Huang; Michael Halagan; Cynthia Vierra-Green; Michael Heuer; Jason E Brelsford; Michael Haagenson; Richard H Scheuermann; Amalio Telenti; William Biggs; Nathaniel M Pearson; Julia Udell; Stephen Spellman; Martin Maiers; Caleb J Kennedy
Journal:  Blood Adv       Date:  2018-10-09

Review 2.  Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.

Authors:  Juliet N Barker; Joanne Kurtzberg; Karen Ballen; Michael Boo; Claudio Brunstein; Corey Cutler; Mitchell Horwitz; Filippo Milano; Amanda Olson; Stephen Spellman; John E Wagner; Colleen Delaney; Elizabeth Shpall
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-06       Impact factor: 5.742

3.  Modeling coverage gaps in haplotype frequencies via Bayesian inference to improve stem cell donor selection.

Authors:  Yoram Louzoun; Idan Alter; Loren Gragert; Mark Albrecht; Martin Maiers
Journal:  Immunogenetics       Date:  2017-11-09       Impact factor: 2.846

4.  Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.

Authors:  Eric Davis; Sean Devlin; Candice Cooper; Melissa Nhaissi; Jennifer Paulson; Deborah Wells; Andromachi Scaradavou; Sergio Giralt; Esperanza Papadopoulos; Nancy A Kernan; Courtney Byam; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2017-12-26       Impact factor: 5.742

5.  Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.

Authors:  Joseph Pidala; Tatenda G Mupfudze; Tammy Payton; Juliet Barker; Miguel-Angel Perales; Bronwen E Shaw; Marcelo Fernández-Viña; Linda J Burns; Jason Dehn
Journal:  Biol Blood Marrow Transplant       Date:  2019-08-13       Impact factor: 5.742

6.  Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.

Authors:  Mary Joseph Acevedo; Jennifer S Wilder; Sharon Adams; Joie Davis; Corin Kelly; Dianne Hilligoss; Ellen Carroll; Bazetta Blacklock-Schuver; Kristen Cole; Elizabeth M Kang; Amy P Hsu; Christopher G Kanakry; Dimana Dimitrova; Jennifer A Kanakry
Journal:  Biol Blood Marrow Transplant       Date:  2019-04-12       Impact factor: 5.742

7.  HLA alleles and haplotypes observed in 263 US families.

Authors:  Kazutoyo Osoegawa; Kalyan C Mallempati; Sridevi Gangavarapu; Arisa Oki; Ketevan Gendzekhadze; Susana R Marino; Nicholas K Brown; Maria P Bettinotti; Eric T Weimer; Gonzalo Montero-Martín; Lisa E Creary; Tamara A Vayntrub; Chia-Jung Chang; Medhat Askar; Steven J Mack; Marcelo A Fernández-Viña
Journal:  Hum Immunol       Date:  2019-06-27       Impact factor: 2.850

8.  Optimal Donor Selection for Hematopoietic Cell Transplantation Using Bayesian Machine Learning.

Authors:  Brent R Logan; Martin J Maiers; Rodney A Sparapani; Purushottam W Laud; Stephen R Spellman; Robert E McCulloch; Bronwen E Shaw
Journal:  JCO Clin Cancer Inform       Date:  2021-05

9.  Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.

Authors:  Jason Dehn; Pintip Chitphakdithai; Bronwen E Shaw; Abby A McDonald; Steven M Devine; Linda J Burns; Stephen Spellman
Journal:  Transplant Cell Ther       Date:  2020-10-10

10.  MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.

Authors:  Shay Ben Shachar; Noam Barda; Sigal Manor; Sapir Israeli; Noa Dagan; Shai Carmi; Ran Balicer; Bracha Zisser; Yoram Louzoun
Journal:  J Clin Immunol       Date:  2021-05-29       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.